Companies

Sintx Technologies, Inc.

SINT · CIK 0001269026 · operating

$2.83-1.05%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$10.86M
P/E
Fwd P/E-1.32
PEG
P/S8.55
P/B2.51
EV/EBITDA-0.89
EV/Rev6.51

Profitability

Gross Margin71.91%
Op. Margin-486.56%
Net Margin-381.85%
ROE-283.10%
ROA-117.11%
FCF Margin-323.24%

Financial Health

Current Ratio2.41
Debt/Equity1.42
Free Cash Flow-$9.33M
Div. Yield

Growth & Other

Revenue Growth9.90%
EPS Growth-385.30%
Beta0.67
52W High$6.78
52W Low$1.71

About Sintx Technologies, Inc.

Sintx Technologies is an advanced ceramics company focused on developing and commercializing medical devices manufactured from silicon nitride. The company specializes in silicon nitride materials for biomedical applications, leveraging the material's antimicrobial and biocompatible properties. Its product portfolio includes solid and porous silicon nitride, silicon nitride powder, and coating products, along with composite materials incorporating polyether ether ketone and polyetherketoneketone polymers. The company operates in surgical instruments and medical devices with applications across orthopedic, spinal, and other surgical specialties.

The company maintains a minimal operational footprint with approximately 20 full-time employees and is headquartered in Salt Lake City, Utah. Sintx operates on a development and commercialization model, indicating early to mid-stage revenue generation from its silicon nitride platform technology. The company was incorporated in Delaware in 1996 and previously operated under the name Amedica Corporation before rebranding as Sintx Technologies. Its geographic focus is primarily the United States, though its advanced materials platform positions it for potential international distribution as product commercialization progresses.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-15.19$-14.87-385.3%
2023$-3.13$-2.22+94.9%
2022$-60.81$-54.67-15902.6%
2021$-0.38$-0.36+64.8%
2020$-1.08$-1.01+81.0%
2019$-5.69$-4.82-122.3%
2018$-2.56$-2.06
2017
2016
2015
2014

Annual Reports (10-K) · 12 filings

Report DateFiledAccession Number
2024-12-312025-03-190001493152-25-010870SEC ↗
2023-12-312024-03-270001493152-24-011546SEC ↗
2022-12-312023-03-290001493152-23-009492SEC ↗
2021-12-312022-03-250001493152-22-007776SEC ↗
2020-12-312021-03-220001493152-21-006489SEC ↗
2019-12-312020-03-260001493152-20-004745SEC ↗
2018-12-312019-03-110001493152-19-003059SEC ↗
2017-12-312018-03-290001493152-18-004186SEC ↗
2016-12-312017-09-200001493152-17-010752SEC ↗
2015-12-312016-03-230001493152-16-008221SEC ↗
2014-12-312015-03-240001564590-15-001941SEC ↗
2013-12-312014-03-310001193125-14-124269SEC ↗